Babis George C, Sakellariou Vasileios I, Pantos Panayiotis G, Sasalos Gregory G, Stavropoulos Nikolaos A
2nd Orthopaedic Department, University of Athens Medical School, Konstantopouleio General Hospital Nea Ionia, Athens, Greece.
1st Department of Orthopaedics, Athens University Medical School, General University Hospital 'Attikon', Haidari, Greece.
J Arthroplasty. 2015 Sep;30(9):1602-6. doi: 10.1016/j.arth.2015.04.004. Epub 2015 Apr 17.
We retrospectively reviewed the medical records of 31 patients with periprosthetic hip infections attempting to evaluate the outcome of a two-stage revision protocol characterized by prolonged interim period (mean=9.2 months, range 8-12 months) prior to the final re-implantation. In 3 cases (9.6%) the 1st stage was repeated after a mean period of 12.3 weeks due to relapse of infection. Five spacer dislocations occurred, not affecting the final clinical outcome after reimplantation, as evaluated by the Harris Hip Score. No protrusions or additional acetabular bone loss was noticed. Our proposed protocol is a simple, safe, efficient and reproducible treatment approach that may be successfully utilized predominantly when dealing with multidrug resistant pathogens.
我们回顾性分析了31例人工髋关节感染患者的病历,试图评估一种两阶段翻修方案的效果,该方案的特点是在最终重新植入前有较长的过渡期(平均9.2个月,范围8 - 12个月)。3例(9.6%)患者因感染复发,在平均12.3周后进行了第一阶段翻修的重复手术。发生了5例间隔器脱位,但根据Harris髋关节评分评估,这并未影响重新植入后的最终临床结果。未发现髋臼突出或额外的骨质流失。我们提出的方案是一种简单、安全、有效且可重复的治疗方法,主要在应对多重耐药病原体时可能成功应用。